[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Precigen Inc (PGEN)

Precigen Inc (PGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Precigen Inc 20374 Seneca Meadows Parkway Germantown MD 20876 USA

www.precigen.com Employees: 160 P: 301-556-9900

Sector:

Medical

Description:

Precigen Inc. is a biopharmaceutical company. It specialise in the development of gene and cell therapies for immuno-oncology, autoimmune disorders and infectious diseases. The company's transformative therapeutic platforms, including UltraCAR-T(TM), AdenoVerse(TM) cytokine therapies, multifunctional therapeutics and off-the-shelf AdenoVerse(TM) immunotherapies, as well as ActoBio Therapeutics, Exemplar Genetics and Triple-Gene from our subsidiaries. Precigen Inc., formerly known as Intrexon Corporation, is based in Germantown, Maryland.

Key Statistics

Overview:

Market Capitalization, $K 1,444,030
Enterprise Value, $K 1,506,970
Shares Outstanding, K 353,929
Float, K 187,228
% Float 52.90%
Short Interest, K 39,795
Short Float 11.24%
Days to Cover 10.77
Short Volume Ratio 0.63
% of Insider Shareholders 47.10%
% of Institutional Shareholders 33.51%

Financials:

Annual Sales, $ 9,680 K
Annual Net Income, $ -250,640 K
Last Quarter Sales, $ 4,570 K
Last Quarter Net Income, $ -23,500 K
EBIT, $ -106,610 K
EBITDA, $ -101,350 K

Growth:

1-Year Return 160.83%
3-Year Return 234.43%
5-Year Return -37.61%
5-Year Revenue Growth -90.62%
5-Year Earnings Growth -160.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.01 on 03/25/26
Next Earnings Date 05/13/26 [--]
Earnings Per Share ttm -0.30
EPS Growth vs. Prev Qtr 90.91%
EPS Growth vs. Prev Year 75.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Most Recent Dividend 0.162 on 06/09/15
Dividend Payout Ratio 0.00%

PGEN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 208.00
Price/Earnings to Growth N/A
Return-on-Equity % 2,317.96%
Return-on-Assets % 49.65%
Profit Margin % -2,589.26%
Debt/Equity 4.46
Price/Sales 152.04
Price/Cash Flow N/A
Price/Book 70.39
Book Value/Share 0.06
Interest Coverage -63.76
60-Month Beta 1.07
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.